Comparison of gastrointestinal adverse effects between cyclooxygenase-2 inhibitors and non-selective, non-steroidal anti-inflammatory drugs plus proton pump inhibitors: a systematic review and meta-analysis

A fixed-dose combination of naproxen and esomeprazole magnesium has comparable upper gastrointestinal tolerability to celecoxib in patients with osteoarthritis of the knee: Results from two randomized, parallel-group, placebo-controlled trials

(2011) Byron L. Cryer et al.   ANNALS OF MEDICINE

Meta-analysis

(2011) Xin Wang et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial

(2010) Francis KL Chan et al.   LANCET

Guidelines for Prevention of NSAID-Related Ulcer Complications

(2009) Frank L Lanza et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Intestinal permeability in the pathogenesis of NSAID-induced enteropathy

(2009) Ingvar Bjarnason et al.   JOURNAL OF GASTROENTEROLOGY

A Novel Composite Endpoint to Evaluate the Gastrointestinal (GI) Effects of Nonsteroidal Antiinflammatory Drugs Through the Entire GI Tract

(2009) F. K. L. CHAN et al.   JOURNAL OF RHEUMATOLOGY

Canadian consensus guidelines on long-term nonsteroidal anti-inflammatory drug therapy and the need for gastroprotection: benefits versus risks

(2008) A. ROSTOM et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Less Small-Bowel Injury With Lumiracoxib Compared With Naproxen Plus Omeprazole

(2008) Christopher J. Hawkey et al.   Clinical Gastroenterology and Hepatology

NSAIDs, Risks, and Gastroprotective Strategies: Current Status and Future

(2008) David Y. Graham et al.   GASTROENTEROLOGY